Target intelligence / Profile preview

RNA, U1 small nuclear 63, pseudogene (RNU1-63P)

Target
RNU1-63P
Molecular classification
Other (non-coding RNA, pseudogene)
01

Overview

RNU1-63P is classified as a pseudogene of the U1 small nuclear RNA family, located in the human genome at cytogenetic region 4:67429591-67429754[3][4][5]. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they generally do not produce functional RNA or protein products. In the case of RNU1-63P, there is no evidence supporting its expression as a functional gene or involvement in known biological processes, disease mechanisms, or as a pharmacological target[1][3][5]. While canonical U1 snRNA genes (e.g., RNU1-1) play key roles in pre-mRNA splicing as core components of the spliceosome, RNU1-63P itself is not known to encode a functional RNA and is not considered a therapeutic target or biomarker[1][2][3]. No drugs or modulators are reported to interact specifically with RNU1-63P, and it has no recognized role in clinical diagnostics or therapeutics[1][3][5].

Other names
RNU1-63P
02

Biological functions

Other (no known functional role; pseudogene likely non-functional)
03

Disease associations

Other (no established disease associations)

Beyond the preview

Go deeper on RNA, U1 small nuclear 63, pseudogene (RNU1-63P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 63, pseudogene (RNU1-63P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call